{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:18:11Z","timestamp":1792631891529,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"\n PURPOSE:<\/jats:title>\n The purpose of this study is to compare the effect of subscleral trabeculectomy (SST) augmented with mitomycin C (MMC) versus Ologen implant as secondary procedures for treatment of primary congenital glaucoma.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n This is a retrospective study evaluating records of 38 eyes that had undergone SST with MMC (Group M, 17 eyes) versus Ologen (Group O, 21 eyes) by the authors of the study. The study primary endpoint was set at 5\u20139 months postoperatively, and the secondary endpoint was the last follow-up. A successful outcome was an intraocular pressure (IOP) \u226418 mmHg for infants <1 year and \u226420 mmHg for older ones.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n The follow-up duration was 1.25\u201351 (26.79 \u00b1 27.583) months in Group M and 0.25\u2013103 (22.86 \u00b1 28.991) months in Group O (\n P<\/jats:italic>\n = 0.673). The mean preoperative IOP was 28.06 \u00b1 3.929 in Group M and 26.95 \u00b1 6.095 in Group O (\n P<\/jats:italic>\n = 0.522). A reduction of IOP was significant in Group M at all follow-up visits but starting at the 4\n th<\/jats:sup>\n postoperative month in Group O. Recorded IOP in Groups M and O, respectively, was 14.9 \u00b1 6.437 and 12.1 \u00b1 5.043 at the primary endpoint and 22.35 \u00b1 8.536 and 22.52 \u00b1 10.152 (\n P<\/jats:italic>\n > 0.05) at the secondary endpoint. A successful outcome was achieved in Groups M and O, respectively, in 47.1% and 47.6% at the primary endpoint and in 47.1% and 52.4% at the secondary endpoint (\n P<\/jats:italic>\n > 0.05). Cataract, posterior synechiae, and pupillary abnormalities were insignificantly different in both the groups (\n P<\/jats:italic>\n = 0.623).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n Ologen implant was comparable to MMC in terms of efficacy and safety. Reoperations are inadvisable before 4 months of Ologen implants.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/sjopt.sjopt_204_23","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T06:00:10Z","timestamp":1708495210000},"page":"352-359","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Subscleral trabeculectomy with Ologen implant versus mitomycin C in primary infantile glaucoma"],"prefix":"10.4103","volume":"38","author":[{"given":"Rehab R.","family":"Kassem","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanne F.","family":"Esmael","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1167\/iovs.06-1350","article-title":"The British infantile and childhood glaucoma (BIG) eye study","volume":"48","author":"Papadopoulos","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/ICU.0000000000000349","article-title":"Pediatric glaucoma: Review of recent literature","volume":"28","author":"Giangiacomo","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archopht.1983.01040010795021","article-title":"Histologic characteristics of filtering blebs in glaucomatous eyes","volume":"101","author":"Addicks","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1136\/bjo.2008.140939","article-title":"Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-C in primary open-angle glaucoma","volume":"92","author":"Reibaldi","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00417-007-0744-9","article-title":"Tissue bioengineering for surgical bleb defects: An animal study","volume":"246","author":"Hsu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000334790","article-title":"Wound healing and glaucoma surgery: Modulating the scarring process with conventional antimetabolites and new molecules","volume":"50","author":"Holl\u00f3","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/IJG.0b013e3181e3d2f7","article-title":"Intraoperative mitomycin C for nonpenetrating glaucoma surgery: A systematic review and meta-analysis","volume":"20","author":"Cheng","year":"2011","journal-title":"J Glaucoma"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.survophthal.2012.01.008","article-title":"Wound modulation after filtration surgery","volume":"57","author":"Seibold","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1586\/eop.09.38","article-title":"New devices in glaucoma surgery","volume":"4","author":"Rao","year":"2009","journal-title":"Exp Rev Ophthalmol"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1586\/17469899.3.6.613","article-title":"Biodegradable collagen matrix implant for trabeculectomy","volume":"3","author":"Zelefsky","year":"2008","journal-title":"Exp Rev Ophthalmol"},{"key":"R11-20260427","first-page":"55","article-title":"Evaluation of subconjual oculusgen implantation as an adjunct to trabnctiveculectomy","volume":"22","author":"Nilforushan","year":"2010","journal-title":"Iran J Ophthalmol"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/eye.2011.219","article-title":"Biodegradable collagen matrix implant versus mitomycin-C as an adjuvant in trabeculectomy: A 24-month, randomized clinical trial","volume":"25","author":"Cillino","year":"2011","journal-title":"Eye (Lond)"},{"key":"R13-20260427","first-page":"3","article-title":"Comparison of the success rate of trabeculectomy with oculusgen versus trabeculectomy with mitomycin C","volume":"23","author":"Nilforushan","year":"2011","journal-title":"Iran J Ophthalmolo"},{"key":"R14-20260427","first-page":"330","article-title":"To Compare the Outcome, Complications and Management of Complications of Trabeculectomy with Ologen Implant Versus Trabeculectomy with MMC","author":"Mitra","year":"2012","journal-title":"Glaucoma-II Free Papers"},{"key":"R15-20260427","first-page":"363","article-title":"Comparative Study of MMC Augmented Trabeculecto-My Versus an Ologen Implant in Open Angle Glaucoma","author":"Maheshwari","year":"2012","journal-title":"Glaucoma-II Free Papers"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4103\/0301-4738.109520","article-title":"Comparison of outcomes of trabeculectomy with mitomycin C versus ologen implant in primary glaucoma","volume":"61","author":"Senthil","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/jop.2012.0120","article-title":"Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma","volume":"29","author":"Marey","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1755-3768.2009.01753.x","article-title":"Trabeculectomy with OloGen versus trabeculectomy for the treatment of glaucoma: A pilot study","volume":"88","author":"Papaconstantinou","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/eye.2010.106","article-title":"A prospective randomised trial of trabeculectomy using mitomycin C versus an ologen implant in open angle glaucoma","volume":"24","author":"Rosentreter","year":"2010","journal-title":"Eye (Lond)"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1111\/aos.12634","article-title":"Is viscotrabeculotomy superior to conventional trabeculotomy in the management of Egyptian infants with congenital glaucoma?","volume":"93","author":"ElSheikha","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41433-021-01633-8","article-title":"Normal intraocular pressure in Egyptian children and meta-analysis","volume":"36","author":"Moussa","year":"2022","journal-title":"Eye (Lond)"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000456719","article-title":"Trabeculectomy with ologen versus mitomycin C in juvenile open-angle glaucoma: A 1-year study","volume":"57","author":"El-Sayyad","year":"2017","journal-title":"Ophthalmic Res"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5301\/ejo.5000859","article-title":"Safety and efficacy of collagen matrix implantation in infantile glaucoma","volume":"27","author":"Elhefney","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"R24-20260427","doi-asserted-by":"crossref","first-page":"9241459","DOI":"10.1155\/2017\/9241459","article-title":"A comparative study: The use of collagen implant versus mitomycin-C in combined trabeculotomy and trabeculectomy for treatment of primary congenital glaucoma","volume":"2017","author":"Singab","year":"2017","journal-title":"J Ophthalmol"},{"key":"R25-20260427","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/112067210901900208","article-title":"Ultrasound biomicroscopy and optical coherence tomography imaging of filtering blebs after deep sclerectomy with new collagen implant","volume":"19","author":"Aptel","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R26-20260427","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/IJG.0b013e31826ab6b1","article-title":"Surgical outcome of mitomycin C-soaked collagen matrix implant in trabeculectomy","volume":"22","author":"Min","year":"2013","journal-title":"J Glaucoma"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_204_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:52:49Z","timestamp":1786647169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_204_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/sjopt.sjopt_204_23","relation":{},"ISSN":["1319-4534","2542-6680"],"issn-type":[{"value":"1319-4534","type":"print"},{"value":"2542-6680","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"2023-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}